Active 0 6 0 6 O
, 6 7 6 7 O
uncontrolled 8 20 8 20 O
bacterial 21 30 21 30 B-chronic_disease
, 30 31 30 31 O
viral 32 37 32 37 B-chronic_disease
, 37 38 37 38 O
or 39 41 39 41 O
fungal 42 48 42 48 B-chronic_disease
infections 49 59 49 59 I-chronic_disease
, 59 60 59 60 O
requiring 61 70 61 70 O
systemic 71 79 71 79 B-treatment
therapy 80 87 80 87 I-treatment

At 0 2 88 90 O
least 3 8 91 96 O
2 9 10 97 98 B-lower_bound
weeks 11 16 99 104 I-lower_bound
since 17 22 105 110 O
the 23 26 111 114 O
last 27 31 115 119 B-treatment
systemic 32 40 120 128 I-treatment
therapy 41 48 129 136 I-treatment
or 49 51 137 139 O
radiotherapy 52 64 140 152 B-treatment
regimen 65 72 153 160 I-treatment
prior 73 78 161 166 O
to 79 81 167 169 O
enrolment 82 91 170 179 O

Controlled 0 10 180 190 O
brain 11 16 191 196 B-cancer
metastases 17 27 197 207 I-cancer
that 28 32 208 212 O
require 33 40 213 220 O
continuous 41 51 221 231 O
high 52 56 232 236 O
dose 57 61 237 241 O
corticosteroid 62 76 242 256 B-treatment
use 77 80 257 260 O
within 81 87 261 267 O
4 88 89 268 269 B-upper_bound
weeks 90 95 270 275 I-upper_bound
of 96 98 276 278 O
Day 99 102 279 282 O
1 103 104 283 284 O

ECOG 0 4 285 289 B-clinical_variable
PS 5 7 290 292 I-clinical_variable
0 8 9 293 294 B-lower_bound
or 10 12 295 297 O
1 13 14 298 299 B-upper_bound

History 0 7 300 307 O
of 8 10 308 310 O
relevant 11 19 311 319 O
coronary 20 28 320 328 B-chronic_disease
heart 29 34 329 334 I-chronic_disease
disease 35 42 335 342 I-chronic_disease
or 43 45 343 345 O
myocardial 46 56 346 356 B-chronic_disease
infarction 57 67 357 367 I-chronic_disease
within 68 74 368 374 O
last 75 79 375 379 B-upper_bound
3 80 81 380 381 I-upper_bound
years 82 87 382 387 I-upper_bound

Known 0 5 388 393 O
infection 6 15 394 403 B-chronic_disease
with 16 20 404 408 O
HIV 21 24 409 412 B-chronic_disease
, 24 25 412 413 O
or 26 28 414 416 O
an 29 31 417 419 O
active 32 38 420 426 B-chronic_disease
infection 39 48 427 436 I-chronic_disease
with 49 53 437 441 O
hepatitis 54 63 442 451 B-chronic_disease
B 64 65 452 453 I-chronic_disease
or 66 68 454 456 O
hepatitis 69 78 457 466 B-chronic_disease
C 79 80 467 468 I-chronic_disease

Major 0 5 469 474 B-treatment
surgery 6 13 475 482 I-treatment
, 13 14 482 483 O
other 15 20 484 489 O
than 21 25 490 494 O
diagnostic 26 36 495 505 O
surgery 37 44 506 513 O
, 44 45 513 514 O
within 46 52 515 521 O
4 53 54 522 523 B-upper_bound
weeks 55 60 524 529 I-upper_bound
prior 61 66 530 535 I-upper_bound
to 67 69 536 538 O
first 70 75 539 544 O
dose 76 80 545 549 O
, 80 81 549 550 O
without 82 89 551 558 O
complete 90 98 559 567 O
recovery 99 107 568 576 O

NYHA 0 4 577 581 B-clinical_variable
Grade 5 10 582 587 B-lower_bound
III 11 14 588 591 I-lower_bound
or 15 17 592 594 O
greater 18 25 595 602 O
congestive 26 36 603 613 B-chronic_disease
heart 37 42 614 619 I-chronic_disease
failure 43 50 620 627 I-chronic_disease

Non 0 3 628 631 B-clinical_variable
- 3 4 631 632 I-clinical_variable
tolerable 4 13 632 641 I-clinical_variable
> 14 15 642 643 O
Grade 16 21 644 649 B-lower_bound
2 22 23 650 651 I-lower_bound
neuropathy 24 34 652 662 B-chronic_disease

Prior 0 5 663 668 O
treatment 6 15 669 678 B-treatment
with 16 20 679 683 O
an 21 23 684 686 O
FTase 24 29 687 692 B-treatment
inhibitor 30 39 693 702 I-treatment

Serum 0 5 703 708 B-clinical_variable
albumin 6 13 709 716 I-clinical_variable
≥ 14 15 717 718 O
3.5 16 19 719 722 B-lower_bound
g 20 21 723 724 I-lower_bound
/ 21 22 724 725 I-lower_bound
dL 22 24 725 727 I-lower_bound

Subject 0 7 728 735 O
consents 8 16 736 744 O
to 17 19 745 747 O
provide 20 27 748 755 O
at 28 30 756 758 O
least 31 36 759 764 O
10 37 39 765 767 B-lower_bound
unstained 40 49 768 777 O
tumor 50 55 778 783 B-cancer
slides 56 62 784 790 O
for 63 66 791 794 O
retrospective 67 80 795 808 O
testing 81 88 809 816 O
of 89 91 817 819 O
HRAS 92 96 820 824 B-treatment
gene 97 101 825 829 O
tumor 102 107 830 835 O
status 108 114 836 842 O

Subject 0 7 843 850 O
has 8 11 851 854 O
measurable 12 22 855 865 B-chronic_disease
disease 23 30 866 873 I-chronic_disease
according 31 40 874 883 O
to 41 43 884 886 O
RECIST 44 50 887 893 O
v1.1 51 55 894 898 O

Subjects 0 8 899 907 O
with 9 13 908 912 O
tumors 14 20 913 919 B-cancer
potentially 21 32 920 931 O
highly 33 39 932 938 O
sensitive 40 49 939 948 O
to 50 52 949 951 O
tipifarnib 53 63 952 962 B-allergy_name
( 64 65 963 964 O
HRAS 65 69 964 968 B-clinical_variable
mutant 70 76 969 975 I-clinical_variable
VAF 77 80 976 979 I-clinical_variable
≥ 81 82 980 981 O
35 83 85 982 984 B-lower_bound
% 85 86 984 985 I-lower_bound
) 86 87 985 986 O
may 88 91 987 990 O
be 92 94 991 993 O
enrolled 95 103 994 1002 O
despite 104 111 1003 1010 O
a 112 113 1011 1012 O
serum 114 119 1013 1018 B-clinical_variable
albumin 120 127 1019 1026 I-clinical_variable
< 128 129 1027 1028 O
3.5 130 133 1029 1032 B-upper_bound
g 134 135 1033 1034 I-upper_bound
/ 135 136 1034 1035 I-upper_bound
dL 136 138 1035 1037 I-upper_bound

atrial 0 6 1038 1044 B-chronic_disease
fibrillation 7 19 1045 1057 I-chronic_disease

cerebro 0 7 1058 1065 B-chronic_disease
- 7 8 1065 1066 I-chronic_disease
vascular 8 16 1066 1074 I-chronic_disease
attack 17 23 1075 1081 I-chronic_disease
within 24 30 1082 1088 O
the 31 34 1089 1092 O
prior 35 40 1093 1098 O
year 41 45 1099 1103 O

evidence 0 8 1104 1112 O
of 9 11 1113 1115 O
unstable 12 20 1116 1124 B-chronic_disease
neurological 21 33 1125 1137 I-chronic_disease
symptoms 34 42 1138 1146 I-chronic_disease
within 43 49 1147 1153 O
4 50 51 1154 1155 B-upper_bound
weeks 52 57 1156 1161 I-upper_bound
first 58 63 1162 1167 O
dose 64 68 1168 1172 O

has 0 3 1173 1176 O
relapsed 4 12 1177 1185 O
or 13 15 1186 1188 O
is 16 18 1189 1191 O
refractory 19 29 1192 1202 O
to 30 32 1203 1205 O
prior 33 38 1206 1211 B-treatment
therapy 39 46 1212 1219 I-treatment

histologically 0 14 1220 1234 O
or 15 17 1235 1237 O
cytologically 18 31 1238 1251 O
confirmed 32 41 1252 1261 O
diagnosis 42 51 1262 1271 O
of 52 54 1272 1274 O
thyroid 55 62 1275 1282 B-cancer
cancer 63 69 1283 1289 I-cancer
( 70 71 1290 1291 O
cohort 71 77 1291 1297 O
1 78 79 1298 1299 O
: 79 80 1299 1300 O
Note 81 85 1301 1305 O
: 85 86 1305 1306 O
Cohort 87 93 1307 1313 O
closed 94 100 1314 1320 O
to 101 103 1321 1323 O
further 104 111 1324 1331 O
enrolment 112 121 1332 1341 O
) 121 122 1341 1342 O
or 123 125 1343 1345 O
Squamous 126 134 1346 1354 B-cancer
Cell 135 139 1355 1359 I-cancer
Carcinoma 140 149 1360 1369 I-cancer
head 150 154 1370 1374 I-cancer
and 155 158 1375 1378 I-cancer
neck 159 163 1379 1383 I-cancer
cancer 164 170 1384 1390 I-cancer
( 171 172 1391 1392 O
cohort 172 178 1392 1398 O
2 179 180 1399 1400 O
) 180 181 1400 1401 O
or 182 184 1402 1404 O
Squamous 185 193 1405 1413 O
Cell 194 198 1414 1418 O
Carcinoma 199 208 1419 1428 O
other 209 214 1429 1434 O
than 215 219 1435 1439 O
HNSCC 220 225 1440 1445 B-cancer
( 226 227 1446 1447 O
cohort 227 233 1447 1453 O
3 234 235 1454 1455 O
) 235 236 1455 1456 O
for 237 240 1457 1460 O
which 241 246 1461 1466 O
there 247 252 1467 1472 O
is 253 255 1473 1475 O
no 256 258 1476 1478 O
curative 259 267 1479 1487 B-treatment
therapy 268 275 1488 1495 I-treatment
available 276 285 1496 1505 O

serious 0 7 1506 1513 O
cardiac 8 15 1514 1521 B-chronic_disease
arrhythmia 16 26 1522 1532 I-chronic_disease
requiring 27 36 1533 1542 O
medication 37 47 1543 1553 O

tumor 0 5 1554 1559 B-cancer
that 6 10 1560 1564 O
carries 11 18 1565 1572 O
a 19 20 1573 1574 O
missense 21 29 1575 1583 O
HRAS 30 34 1584 1588 O
mutation 35 43 1589 1597 O
ith 44 47 1598 1601 O
a 48 49 1602 1603 O
variant 50 57 1604 1611 B-clinical_variable
allele 58 64 1612 1618 I-clinical_variable
frequency 65 74 1619 1628 I-clinical_variable
( 75 76 1629 1630 I-clinical_variable
VAF 76 79 1630 1633 I-clinical_variable
) 79 80 1633 1634 I-clinical_variable
> 81 82 1635 1636 O
20 83 85 1637 1639 B-lower_bound
% 85 86 1639 1640 I-lower_bound

